BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 34191152)

  • 21. Pancreatic serous cystadenocarcinoma diagnosed with liver metastasis at 7 years after the resection of the primary serous neoplastic lesion.
    Takagi Y; Hatori T; Itano O; Shinoda M; Kato A; Nitori N; Kato F; Kato A; Nakao A; Tamura T; Uemura S; Miyazaki M; Aida S
    Clin J Gastroenterol; 2022 Apr; 15(2):505-512. PubMed ID: 35013932
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term follow-up and clinical course of a rare case of von Hippel-Lindau disease: A case report and review of the literature.
    Zou YU; Xu J; Zhang M
    Oncol Lett; 2016 May; 11(5):3273-3278. PubMed ID: 27123102
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diffuse pancreatic serous cystadenoma associated with neuroendocrine carcinoma: a case report and review of literature.
    Agarwal N; Kumar S; Dass J; Arora VK; Rathi V
    JOP; 2009 Jan; 10(1):55-8. PubMed ID: 19129617
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term Prognosis of Resected Pancreatic Neuroendocrine Tumors in von Hippel-Lindau Disease Is Favorable and Not Influenced by Small Tumors Left in Place.
    de Mestier L; Gaujoux S; Cros J; Hentic O; Vullierme MP; Couvelard A; Cadiot G; Sauvanet A; Ruszniewski P; Richard S; Hammel P
    Ann Surg; 2015 Aug; 262(2):384-8. PubMed ID: 25185468
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pancreatic lesions in von Hippel-Lindau syndrome: report of a case.
    Künzli BM; Shrikhande SV; Büchler MW; Friess H
    Surg Today; 2004; 34(7):626-9. PubMed ID: 15221562
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vascular endothelial growth factor, a novel and highly accurate pancreatic fluid biomarker for serous pancreatic cysts.
    Yip-Schneider MT; Wu H; Dumas RP; Hancock BA; Agaram N; Radovich M; Schmidt CM
    J Am Coll Surg; 2014 Apr; 218(4):608-17. PubMed ID: 24491241
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Total pancreatectomy for multiple neuroendocrine tumors of the pancreas in a patient with von Hippel-Lindau disease.
    Maeda H; Nishimori I; Okabayashi T; Kohsaki T; Shuin T; Kobayashi M; Onishi S; Hanazaki K
    Clin J Gastroenterol; 2009 Jun; 2(3):222-225. PubMed ID: 26192301
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Value of retrospective fusion of PET and MR images in detection of hepatic metastases: comparison with 18F-FDG PET/CT and Gd-EOB-DTPA-enhanced MRI.
    Donati OF; Hany TF; Reiner CS; von Schulthess GK; Marincek B; Seifert B; Weishaupt D
    J Nucl Med; 2010 May; 51(5):692-9. PubMed ID: 20395324
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clear cell endocrine pancreatic tumor mimicking renal cell carcinoma: a distinctive neoplasm of von Hippel-Lindau disease.
    Hoang MP; Hruban RH; Albores-Saavedra J
    Am J Surg Pathol; 2001 May; 25(5):602-9. PubMed ID: 11342771
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Two-stage resection of a bilateral pheochromocytoma and pancreatic neuroendocrine tumor in a patient with von Hippel-Lindau disease: A case report.
    Endo Y; Kitago M; Miyajima A; Kurihara I; Kameyama K; Shinoda M; Yagi H; Abe Y; Hibi T; Takagi C; Nakano Y; Koizumi W; Itano O; Kitagawa Y
    Int J Surg Case Rep; 2018; 44():139-142. PubMed ID: 29501019
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Combination of right nephrectomy and total pancreaticoduodenectomy for Von Hippel-Lindau disease.
    Arkadopoulos N; Karapanos K; Stafyla V; Yiallourou A; Koureas A; Kondi-Pafiti A; Smyrniotis V
    JOP; 2010 May; 11(3):270-2. PubMed ID: 20442526
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pancreatic involvement in von Hippel-Lindau disease. The Groupe Francophone d'Etude de la Maladie de von Hippel-Lindau.
    Hammel PR; Vilgrain V; Terris B; Penfornis A; Sauvanet A; Correas JM; Chauveau D; Balian A; Beigelman C; O'Toole D; Bernades P; Ruszniewski P; Richard S
    Gastroenterology; 2000 Oct; 119(4):1087-95. PubMed ID: 11040195
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The diagnostic advantage of EOB-MR imaging over CT in the detection of liver metastasis in patients with potentially resectable pancreatic cancer.
    Ito T; Sugiura T; Okamura Y; Yamamoto Y; Ashida R; Aramaki T; Endo M; Uesaka K
    Pancreatology; 2017; 17(3):451-456. PubMed ID: 28298257
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Biliary and gastric drainage in advanced pancreatic serous cystadenoma and portal hypertension in Von Hippel-Lindau syndrome.
    Medina DC; Osorno R; Boutros CN
    J Gastrointest Oncol; 2014 Apr; 5(2):E50-3. PubMed ID: 24772348
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical features of pancreatic involvement in von Hippel-Lindau disease: a retrospective study of 55 cases in a single center.
    Park TY; Lee SK; Park JS; Oh D; Song TJ; Park DH; Lee SS; Seo DW; Kim MH
    Scand J Gastroenterol; 2015 Mar; 50(3):360-7. PubMed ID: 25562111
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pancreatic lesions in von Hippel-Lindau syndrome: the coexistence of metastatic tumors from renal cell carcinoma and multiple cysts.
    Kogire M; Hosotani R; Kondo M; Itoh K; Doi R; Terachi T; Imamura M
    Surg Today; 2000; 30(4):380-2. PubMed ID: 10795874
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pancreatic neuroendocrine tumors associated with von Hippel Lindau disease: diagnostic and management recommendations.
    Libutti SK; Choyke PL; Bartlett DL; Vargas H; Walther M; Lubensky I; Glenn G; Linehan WM; Alexander HR
    Surgery; 1998 Dec; 124(6):1153-9. PubMed ID: 9854597
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pancreatic mixed serous neuroendocrine neoplasm with clear cells leading to diagnosis of von Hippel Lindau disease.
    Kakkar A; Sharma MC; Yadav R; Panwar R; Mathur SR; Iyer VK; Sahni P
    Pathol Res Pract; 2016 Aug; 212(8):747-50. PubMed ID: 27161305
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Gastroenterological manifestations of von Hippel-Lindau disease].
    Koniusz J; Dąbkowski K; Buczek K; Gomółka A; Starzyńska T
    Pol Merkur Lekarski; 2017 Aug; 43(254):53-55. PubMed ID: 28875969
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serous cystic neoplasms of the pancreas: an immunohistochemical analysis revealing alpha-inhibin, neuron-specific enolase, and MUC6 as new markers.
    Kosmahl M; Wagner J; Peters K; Sipos B; Klöppel G
    Am J Surg Pathol; 2004 Mar; 28(3):339-46. PubMed ID: 15104296
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.